Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about HAVN Life Sciences Inc.
HAVN Life Sciences Inc. News
HAVN Life Sciences Inc. Quantitative Score
About HAVN Life Sciences Inc.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
HAVN Life Sciences Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
HAVN Life Sciences Inc. Financials
Table Compare
Compare HAVLF metrics with: | |||
|---|---|---|---|
Earnings & Growth | HAVLF | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | HAVLF | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | HAVLF | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | HAVLF | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
HAVN Life Sciences Inc. Income
HAVN Life Sciences Inc. Balance Sheet
HAVN Life Sciences Inc. Cash Flow
HAVN Life Sciences Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Neutral |
| Return on Assets | Buy |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Neutral |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
HAVN Life Sciences Inc. Executives
| Name | Role |
|---|---|
| Mr. Tim Moore | Interim Chief Financial Officer, Chief Executive Officer & Chairman |
| Ms. Jenna Pozar | Chief Operations Officer |
| Mr. Paul More | Controller |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Tim Moore | Interim Chief Financial Officer, Chief Executive Officer & Chairman | Male | 1959 | 124.66K |
| Ms. Jenna Pozar | Chief Operations Officer | Female | -- | |
| Mr. Paul More | Controller | Male | -- |